SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2017-03-17
Tx date 2017-03-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-96,581,430
-8,780,130 vol
$11.00 each 		0
Filed 2017-03-17
Tx date 2017-03-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$100,760,022
+2,114,586 vol
$47.65 each 		0
Filed 2017-03-17
Tx date 2017-03-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$85,957,920
+2,114,586 vol
$40.65 each
Filed 2017-03-17
Tx date 2017-03-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$85,957,920
+2,114,586 vol
$40.65 each
Filed 2017-03-17
Tx date 2017-03-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$128,475,502
+2,696,233 vol
$47.65 each 		0
Filed 2017-03-17
Tx date 2017-03-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$3,232,766
+67,844 vol
$47.65 each 		0
Filed 2017-03-17
Tx date 2017-03-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$202,099,708
+4,241,337 vol
$47.65 each 		0
Filed 2017-03-17
Tx date 2017-03-14 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
Listed Calls (including Options to Purchase )
70 - Acquisition or disposition (writing) of third party derivative 		$-6,343.80
-21,146 vol
$0.30 each 		0
Filed 2017-03-17
Tx date 2017-03-14 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
Listed Calls (including Options to Purchase )
70 - Acquisition or disposition (writing) of third party derivative 		$-8,088.60
-26,962 vol
$0.30 each 		0
Filed 2017-03-17
Tx date 2017-03-14 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
Listed Calls (including Options to Purchase )
70 - Acquisition or disposition (writing) of third party derivative 		$-203.40
-678 vol
$0.30 each 		0
Filed 2017-03-17
Tx date 2017-03-14 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Listed Calls (including Options to Purchase )
70 - Acquisition or disposition (writing) of third party derivative 		$-12,724.20
-42,414 vol
$0.30 each 		0
Filed 2017-03-17
Tx date 2017-03-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-28,662,183
-2,605,653 vol
$11.00 each 		0
Filed 2017-03-17
Tx date 2017-03-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-73,671,620
-6,697,420 vol
$11.00 each 		0
Filed 2017-03-17
Tx date 2017-03-13 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-343,519
-31,229 vol
$11.00 each 		0
Filed 2016-12-16
Tx date 2016-12-12 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-49,883,793.30
-3,359,178 vol
$14.85 each 		2,605,653
Filed 2016-12-16
Tx date 2016-12-12 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
70 - Acquisition or disposition (writing) of third party derivative 		$25,315
+2,531,559 vol
$0.01 each 		0
Filed 2016-12-16
Tx date 2016-12-12 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
70 - Acquisition or disposition (writing) of third party derivative 		$28,378
+2,837,875 vol
$0.01 each 		0
Filed 2016-12-16
Tx date 2016-12-12 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
70 - Acquisition or disposition (writing) of third party derivative 		$631.22
+63,122 vol
$0.01 each 		0
Filed 2016-12-16
Tx date 2016-12-12 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
70 - Acquisition or disposition (writing) of third party derivative 		$36,874
+3,687,444 vol
$0.01 each 		0
Filed 2016-12-16
Tx date 2016-12-12 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,745,053.20
-117,512 vol
$14.85 each 		31,229
Filed 2016-08-09
Tx date 2016-08-04 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
Common Shares
15 - Acquisition or disposition under a prospectus 		$-9,674,477.12
-68,284 vol
$141.68 each 		0
Filed 2016-08-09
Tx date 2016-08-04 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
Common Shares
15 - Acquisition or disposition under a prospectus 		$-378,822,708.88
-2,673,791 vol
$141.68 each 		0
Filed 2016-08-09
Tx date 2016-08-04 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
Common Shares
15 - Acquisition or disposition under a prospectus 		$-432,404,243.04
-3,051,978 vol
$141.68 each 		0
Filed 2016-08-09
Tx date 2016-08-04 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Common Shares
15 - Acquisition or disposition under a prospectus 		$-573,355,866.16
-4,046,837 vol
$141.68 each 		0
Filed 2016-06-15
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$-78,427,880.154
-2,114,586 vol
$37.09 each 		-2,114,586
Filed 2016-06-15
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$-78,428,251.044
-2,114,596 vol
$37.09 each
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$-78,427,880.154
-2,114,586 vol
$37.09 each
Filed 2016-06-14
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Listed Calls (including Options to Purchase )
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Listed Calls (including Options to Purchase )
70 - Acquisition or disposition (writing) of third party derivative 		$169,656
+42,414 vol
$4.00 each 		42,414
Filed 2016-06-14
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
Listed Calls (including Options to Purchase )
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
Listed Calls (including Options to Purchase )
70 - Acquisition or disposition (writing) of third party derivative 		$2,712
+678 vol
$4.00 each 		678
Filed 2016-06-14
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
Listed Calls (including Options to Purchase )
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
Listed Calls (including Options to Purchase )
70 - Acquisition or disposition (writing) of third party derivative 		$107,848
+26,962 vol
$4.00 each 		26,962
Filed 2016-06-14
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
Listed Calls (including Options to Purchase )
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
Listed Calls (including Options to Purchase )
70 - Acquisition or disposition (writing) of third party derivative 		$84,584
+21,146 vol
$4.00 each 		21,146
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
70 - Acquisition or disposition (writing) of third party derivative 		$-110,623.32
-3,687,444 vol
$0.03 each 		0
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
70 - Acquisition or disposition (writing) of third party derivative 		$-1,893.66
-63,122 vol
$0.03 each 		0
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
70 - Acquisition or disposition (writing) of third party derivative 		$-85,136.25
-2,837,875 vol
$0.03 each 		0
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
70 - Acquisition or disposition (writing) of third party derivative 		$-75,946.77
-2,531,559 vol
$0.03 each 		0
Filed 2016-06-14
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell)
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$-157,306,947.993
-4,241,337 vol
$37.09 each 		-4,241,337
Filed 2016-06-14
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$-2,516,266.116
-67,844 vol
$37.09 each 		-67,844
Filed 2016-06-14
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell)
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$-100,000,585.737
-2,696,233 vol
$37.09 each 		-2,696,233
Filed 2016-06-14
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$-78,427,880.154
-2,114,586 vol
$37.09 each
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell)
70 - Acquisition or disposition (writing) of third party derivative 		$-78,428,251.044
-2,114,596 vol
$37.09 each 		-2,114,596
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$132,010,495
+3,687,444 vol
$35.80 each
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$132,010,495
+3,687,444 vol
$35.80 each
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$132,010,495
+3,687,444 vol
$35.80 each 		0
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$2,259,767
+63,122 vol
$35.80 each
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$2,259,767
+63,122 vol
$35.80 each
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$2,259,767
+63,122 vol
$35.80 each 		0
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$101,595,924
+2,837,875 vol
$35.80 each
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$101,595,924
+2,837,875 vol
$35.80 each
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$101,595,924
+2,837,875 vol
$35.80 each 		0
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$90,629,812
+2,531,559 vol
$35.80 each
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$90,629,812
+2,531,559 vol
$35.80 each
Filed 2016-06-14
Tx date 2016-06-09 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative 		$90,629,812
+2,531,559 vol
$35.80 each 		0
Filed 2016-04-27
Tx date 2016-04-22 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square, L.P. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-176,258,279.50
-1,188,926 vol
$148.25 each 		2,673,791
Filed 2016-04-27
Tx date 2016-04-22 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square International, Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-188,214,790.25
-1,269,577 vol
$148.25 each 		3,051,978
Filed 2016-04-27
Tx date 2016-04-22 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square II, L.P. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-3,668,298
-24,744 vol
$148.25 each 		68,284
Filed 2016-04-27
Tx date 2016-04-22 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-239,683,632.25
-1,616,753 vol
$148.25 each 		4,046,837
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		6,697,420
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		148,741
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		8,780,130
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
70 - Acquisition or disposition (writing) of third party derivative
-63,122 vol 		-63,122
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
70 - Acquisition or disposition (writing) of third party derivative
-3,687,444 vol 		-3,687,444
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		5,964,831
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative
-63,122 vol 		-63,122
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative
-2,837,875 vol 		-2,837,875
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative
-2,531,559 vol 		-2,531,559
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
70 - Acquisition or disposition (writing) of third party derivative
+3,687,444 vol 		3,687,444
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
70 - Acquisition or disposition (writing) of third party derivative
-2,531,559 vol 		-2,531,559
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
70 - Acquisition or disposition (writing) of third party derivative
-2,837,875 vol 		-2,837,875
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$165.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square II, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
70 - Acquisition or disposition (writing) of third party derivative
+63,122 vol 		63,122
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square International, Ltd. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
70 - Acquisition or disposition (writing) of third party derivative
+2,837,875 vol 		2,837,875
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
70 - Acquisition or disposition (writing) of third party derivative
+2,531,559 vol
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square, L.P. (Control or Direction)
OTC Calls (including Private Options to Purchase) Exercise US$95.00
70 - Acquisition or disposition (writing) of third party derivative
+2,531,559 vol 		2,531,559
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-31
Tx date 2016-03-21 		$VRX
Valeant Pharmaceuticals International, Inc. 		Ackman, William A.
4 - Director of Issuer
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
OTC Puts (including Private Options to Sell) Exercise US$60.00
70 - Acquisition or disposition (writing) of third party derivative
-3,687,444 vol 		-3,687,444
Filed 2015-10-06
Tx date 2015-10-01 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square International, Ltd. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$-14,120,109.50
-98,350 vol
$143.57 each 		4,321,555
Filed 2015-10-06
Tx date 2015-10-01 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$17,758,891
+123,695 vol
$143.57 each 		5,663,590
Filed 2015-10-06
Tx date 2015-10-01 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square, L.P. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$-3,638,781.65
-25,345 vol
$143.57 each
Filed 2015-10-06
Tx date 2015-10-01 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square, L.P. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$-3,638,781.65
-25,345 vol
$143.57 each
Filed 2015-10-06
Tx date 2015-10-01 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square, L.P. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$-3,638,781.65
-25,345 vol
$143.57 each 		3,862,717
Filed 2015-08-07
Tx date 2015-08-03 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square International, Ltd. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$20,528,481
+127,625 vol
$160.85 each 		4,419,905
Filed 2015-08-07
Tx date 2015-08-03 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$-14,348,141.70
-89,202 vol
$160.85 each 		5,539,895
Filed 2015-08-07
Tx date 2015-08-03 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square, L.P. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$-6,180,339.55
-38,423 vol
$160.85 each 		3,888,062
Filed 2015-07-06
Tx date 2015-07-01 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square International, Ltd. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$-37,618,639.17
-234,779 vol
$160.23 each 		4,292,280
Filed 2015-07-06
Tx date 2015-07-01 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$73,790,882
+460,531 vol
$160.23 each 		5,629,097
Filed 2015-07-06
Tx date 2015-07-01 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square II, L.P. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$-993,307.07
-6,221 vol
$159.67 each 		93,028
Filed 2015-07-06
Tx date 2015-07-01 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square Holdings, Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market 		$995,733
+6,221 vol
$160.06 each 		5,168,566
Filed 2015-07-06
Tx date 2015-07-01 		$CP
Canadian Pacific Railway Limited 		Ackman, William A.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Pershing Square, L.P. (Control or Direction)
Common Shares
90 - Change in the nature of ownership 		$-36,172,242.96
-225,752 vol
$160.23 each 		3,926,485